中国P站

ISSN: 2476-2024

Diagnostic Pathology: Open Access
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Diagnos Pathol Open,

Fleischner Society-Guided Follow-up of Incidentally Detected Pulmonary Lesions During the COVID-19 Pandemic Enables Early Lung Cancer Detection While Avoiding Unnecessary Pulmonary Resection

Leyla Nesrin Acar1*, Pınar Bıçakçıoğlu1, Seray Hazer1, Nesrin Gürçay2 and Selim Şakir Erkmen Gülhan1
1Department of Thoracic Surgery, Health and Science University, Ankara Atat眉rk Sanatoryum Training and Research Hospital, Ke莽i枚ren, Ankara, Turkey
2Department of Medical Pathology, Health and Science University, Ankara Atat眉rk Sanatoryum Training and Research Hospital, Department of Surgical Medical sciences, Clinical Cytology (Medicine), Ke莽i枚ren, Ankara, Turkey
*Corresponding Author : Leyla Nesrin Acar, Department of Thoracic Surgery, Health and Science University, Ankara Atat眉rk Sanatoryum Training and Research Hospital, Ke莽i枚ren, Ankara, Turkey, Email: acar8106@gmail.com

Received Date: Sep 28, 2026 / Accepted Date: Oct 28, 2026 / Published Date: Oct 28, 2026

Abstract

Background: The Coronavirus Disease-19 (COVID-19) pandemic markedly increased the use of thoracic Computed Tomography (CT), leading to more incidental detection of pulmonary nodules, Ground-Glass Opacities (GGOs) and pulmonary masses. This study evaluated whether management based on the 2017 fleischner society recommendations improves patient selection for surgery while avoiding unnecessary pulmonary resection.

Methods: This retrospective single-center study included patients who underwent thoracic CT for suspected COVID-19 infection between April 2019 and April 2021. Among 259 patients with incidental pulmonary lesions, those with previous malignancy or incomplete data were excluded. Pulmonary masses underwent immediate multidisciplinary evaluation, whereas GGOs and nodules were managed according to the Fleischner Society recommendations. Persistent or suspicious lesions underwent pulmonary resection. Clinical characteristics, predictors of malignancy, pathology, Overall Survival (OS) and Disease-Free Survival (DFS) were analyzed.

Results: A total of 197 patients were included: 148 (75.1%) had malignant lesions and 49 (24.9%) had benign lesions. During surveillance, 43 patients avoided surgery because of spontaneous lesion regression; complete radiological resolution was confirmed in all 38 patients with available follow-up. Age ≥ 70 years (adjusted OR 5.50; p=0.010), male sex (adjusted OR 2.28; p=0.030) and ≥ 20 pack-year smoking (adjusted OR 3.49; p=0.032) independently predicted malignancy. More than 80% of malignant tumors were Stage I-II. five-year OS and DFS were 87.2% and 92.6%, respectively.

Conclusion: Fleischner society-guided surveillance reduced unnecessary pulmonary resections while facilitating early diagnosis of surgically curable lung cancer. Guideline-based follow-up combined with multidisciplinary evaluation achieved excellent long-term oncological outcomes and should remain the preferred strategy for managing incidentally detected pulmonary lesions.

Keywords: COVID-19; Pulmonary nodule; Fleischner society; Computed tomography; Lung cancer; Pulmonary resection; Overall survival; Disease-free survival.

Citation: Acar LN, B脛卤çakç脛卤o脛聼lu P, Hazer S, Gürçay N,  Gülhan SSE, et al.  (2026) Fleischner Society-Guided Follow-up of Incidentally Detected Pulmonary Lesions During the COVID-19 Pandemic Enables Early Lung Cancer Detection While Avoiding Unnecessary Pulmonary Resection. Diagnos Pathol Open 11:280.

Copyright: © 2026 Acar LN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 99
  • [From(publication date): 0-0 - Nov 20, 2026]
  • Breakdown by view type
  • HTML page views: 78
  • PDF downloads: 21
International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top